Name | Number of supported studies | Average coverage | |
---|---|---|---|
oligodendrocyte | 7 studies | 28% ± 8% | |
endothelial cell | 6 studies | 28% ± 10% | |
microglial cell | 6 studies | 24% ± 6% | |
macrophage | 5 studies | 26% ± 6% | |
epithelial cell | 5 studies | 28% ± 9% | |
astrocyte | 5 studies | 30% ± 9% | |
GABAergic neuron | 4 studies | 37% ± 12% | |
glutamatergic neuron | 4 studies | 42% ± 16% | |
oligodendrocyte precursor cell | 4 studies | 30% ± 9% | |
dendritic cell | 3 studies | 17% ± 2% | |
smooth muscle cell | 3 studies | 16% ± 0% |
Name | Number of supported studies | Average coverage | |
---|---|---|---|
brain | 5 studies | 39% ± 10% |
Tissue | GTEx Coverage | GTEx Average TPM | GTEx Number of samples | TCGA Coverage | TCGA Average TPM | TCGA Number of samples |
---|---|---|---|---|---|---|
esophagus | 100% | 2782.72 | 1445 / 1445 | 100% | 42.43 | 183 / 183 |
intestine | 100% | 3210.19 | 966 / 966 | 100% | 31.88 | 527 / 527 |
lung | 100% | 2912.96 | 578 / 578 | 100% | 26.01 | 1155 / 1155 |
stomach | 100% | 2349.95 | 359 / 359 | 100% | 37.19 | 286 / 286 |
ovary | 100% | 3085.59 | 180 / 180 | 100% | 19.31 | 429 / 430 |
breast | 100% | 2759.54 | 459 / 459 | 99% | 28.33 | 1112 / 1118 |
uterus | 100% | 2903.01 | 170 / 170 | 99% | 26.34 | 455 / 459 |
thymus | 100% | 4340.41 | 653 / 653 | 99% | 21.35 | 599 / 605 |
bladder | 100% | 3253.33 | 21 / 21 | 99% | 23.56 | 499 / 504 |
prostate | 100% | 2683.62 | 245 / 245 | 99% | 20.40 | 496 / 502 |
brain | 98% | 1917.40 | 2602 / 2642 | 100% | 18.94 | 704 / 705 |
pancreas | 99% | 1720.07 | 326 / 328 | 99% | 18.06 | 176 / 178 |
kidney | 100% | 2525.25 | 89 / 89 | 98% | 18.57 | 882 / 901 |
skin | 100% | 3864.35 | 1809 / 1809 | 98% | 23.77 | 461 / 472 |
adrenal gland | 100% | 2599.79 | 258 / 258 | 93% | 10.48 | 214 / 230 |
liver | 100% | 1691.73 | 226 / 226 | 86% | 9.67 | 350 / 406 |
adipose | 100% | 2804.06 | 1204 / 1204 | 0% | 0 | 0 / 0 |
blood vessel | 100% | 3460.44 | 1335 / 1335 | 0% | 0 | 0 / 0 |
lymph node | 0% | 0 | 0 / 0 | 100% | 21.83 | 29 / 29 |
muscle | 100% | 5396.86 | 803 / 803 | 0% | 0 | 0 / 0 |
spleen | 100% | 2944.88 | 241 / 241 | 0% | 0 | 0 / 0 |
tonsil | 0% | 0 | 0 / 0 | 100% | 25.00 | 45 / 45 |
ureter | 0% | 0 | 0 / 0 | 100% | 6.55 | 1 / 1 |
heart | 98% | 1771.22 | 841 / 861 | 0% | 0 | 0 / 0 |
peripheral blood | 88% | 2106.84 | 813 / 929 | 0% | 0 | 0 / 0 |
eye | 0% | 0 | 0 / 0 | 85% | 8.59 | 68 / 80 |
abdomen | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
bone marrow | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
diaphragm | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
gingiva | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasal cavity | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nasopharynx | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
nose | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
placenta | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
spinal column | 0% | 0 | 0 / 0 | 0% | 0 | 0 / 0 |
GO_0051123 | Biological process | RNA polymerase II preinitiation complex assembly |
GO_0060261 | Biological process | positive regulation of transcription initiation by RNA polymerase II |
GO_0045893 | Biological process | positive regulation of DNA-templated transcription |
GO_0035019 | Biological process | somatic stem cell population maintenance |
GO_0032968 | Biological process | positive regulation of transcription elongation by RNA polymerase II |
GO_0045944 | Biological process | positive regulation of transcription by RNA polymerase II |
GO_0006357 | Biological process | regulation of transcription by RNA polymerase II |
GO_0016592 | Cellular component | mediator complex |
GO_0005654 | Cellular component | nucleoplasm |
GO_0016020 | Cellular component | membrane |
GO_0070847 | Cellular component | core mediator complex |
GO_0005634 | Cellular component | nucleus |
GO_0003713 | Molecular function | transcription coactivator activity |
GO_0042809 | Molecular function | nuclear vitamin D receptor binding |
GO_0030374 | Molecular function | nuclear receptor coactivator activity |
GO_0005515 | Molecular function | protein binding |
GO_0003712 | Molecular function | transcription coregulator activity |
Gene name | MED14 |
Protein name | Mediator complex subunit 14 Mediator of RNA polymerase II transcription subunit 14 (Activator-recruited cofactor 150 kDa component) (ARC150) (Cofactor required for Sp1 transcriptional activation subunit 2) (CRSP complex subunit 2) (Mediator complex subunit 14) (RGR1 homolog) (hRGR1) (Thyroid hormone receptor-associated protein complex 170 kDa component) (Trap170) (Transcriptional coactivator CRSP150) (Vitamin D3 receptor-interacting protein complex 150 kDa component) (DRIP150) Mediator of RNA polymerase II transcription subunit 14 (Mediator complex subunit 14) |
Synonyms | TRAP170 CRSP2 DRIP150 RGR1 ARC150 CXorf4 EXLM1 |
Description | FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. . FUNCTION: Component of the Mediator complex, a coactivator involved in the regulated transcription of nearly all RNA polymerase II-dependent genes. Mediator functions as a bridge to convey information from gene-specific regulatory proteins to the basal RNA polymerase II transcription machinery. Mediator is recruited to promoters by direct interactions with regulatory proteins and serves as a scaffold for the assembly of a functional preinitiation complex with RNA polymerase II and the general transcription factors. . |
Accessions | O60244 H7C3E5 ENST00000433003.1 ENST00000324817.6 ENST00000416199.5 U4PZJ2 H7C017 |